Discover Human PVRL4: Enhance Performance with Expert Insights

Alpha Lifetech Incorporation proudly presents a groundbreaking advancement in the field of cellular biology with our latest product centered on the Human PvrL4 protein. PVRL4, a key player in various cellular processes, has emerged as a critical component in the development of innovative therapies and diagnostic tools. This product offers researchers an invaluable resource for exploring the intricate roles of PVRL4 in cell adhesion and immune response, Designed for versatility, our PVRL4 product is ideal for a wide range of applications, from fundamental research to clinical studies. Researchers can harness the potential of this protein to uncover insights into disease mechanisms and therapeutic targets, particularly in cancer and autoimmune disorders, With the commitment to quality and reliability, Alpha Lifetech ensures that each product meets the highest standards, empowering scientists to advance their work with confidence. Explore the potential of human PVRL4 and join us in pioneering the future of biomedical research

Hot Selling Product

ALP64513-Recombinant Human TNFRSF17/BCMA Protein, His Tag, Flag Tag

ALP64515-Recombinant Human CD73 Protein, Fc Tag

ALP64517-Recombinant Human CD223/LAG3 Protein, His Tag, Avi Tag

ALP64522-Recombinant Human BTLA/CD272 Protein, mFc Tag

ALP64523-Recombinant Human Biotinylated FGL1 Protein, Avi Tag, His Tag

ALP64524-Recombinant Human TNFRSF17/BCMA Protein, Fc Tag, Avi Tag

Curated Selection of human PVRL4 Supplies the World’s Top Brands Supplier

In the world of biotechnology, the demand for high-quality reagents continues to rise, driven by the need for innovative solutions and reliable research tools. Alpha Lifetech Inc. stands at the forefront of this industry, offering a curated selection of human PVRL4 supplies that meet the stringent requirements of the world’s top brands. With nearly 10,000 spot membrane protein reagents, cytokines, and drug target antibodies in our portfolio, we empower researchers and companies to achieve their scientific goals with confidence. Founded by a team of seasoned scientists, Alpha Lifetech Inc. emphasizes quality and reliability in every product. Our extensive experience in membrane protein production and monoclonal development enables us to deliver reagents that are not only robust but also tailored to the specific needs of our clients. By choosing our human PVRL4 supplies, global purchasers gain access to cutting-edge tools that are essential for advancing research in areas such as cell signaling, immunology, and beyond. At Alpha Lifetech Inc., we are committed to fostering innovation and supporting the global scientific community. Our partnership with leading brands demonstrates our dedication to quality and excellence. We invite you to explore our offerings and experience the difference that high-quality reagents can make in your research and development endeavors. With our human PVRL4 supplies, you can trust that you are backed by expertise, quality assurance, and a commitment to scientific advancement.

Curated Selection of Human PVRL4 Supplies the World’s Top Brands Supplier

Product Name	Supplier Country	Supply Volume (Units)	Price per Unit (USD)	Availability Status
PVRL4 Antibody	USA	500	120.00	In Stock
PVRL4 Recombinant Protein	Germany	300	250.00	Pre-order
PVRL4 ELISA Kit	UK	200	150.00	In Stock
PVRL4 Protein Control	Canada	100	100.00	Out of Stock

Comparison of Global Manufacturing Output for Human PVRL4 Supplies (2020-2023)

The chart above illustrates the growth trend of global manufacturing output for human PVRL4 supplies from 2020 to 2023. The data indicates a steady increase in output over the years, showcasing a rising demand for these supplies in various applications. Starting in 2020, the manufacturing output was recorded at 15,000 units, indicating a moderate production level. By 2021, there was a significant jump to 25,000 units, reflecting an increased market interest and possibly new applications for PVRL4 supplies. The year 2022 saw further growth with output reaching 35,000 units, illustrating robust market dynamics and possibly improvements in manufacturing efficiency. In 2023, a projected output of 45,000 units suggests a continuing trend of increased production to meet Global demands. This data highlights the crucial role of PVRL4 supplies in the market and indicates a promising future for manufacturers involved in this sector.